Risk Stratification in Hypertrophic Cardiomyopathy: Highly Effective, But Could It Be Better?
Circ Cardiovasc Imaging
.
2017 Jul;10(7):e006674.
doi: 10.1161/CIRCIMAGING.117.006674.
Author
Martin S Maron
1
Affiliation
1
From the Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, MA. mmaron@tuftsmedicalcenter.org.
PMID:
28679525
DOI:
10.1161/CIRCIMAGING.117.006674
No abstract available
Keywords:
Editorials; biomarkers; cardiomyopathy, hypertrophic; death, sudden; gadolinium; risk.
Publication types
Editorial
Comment
MeSH terms
Cardiomyopathy, Hypertrophic*
Death, Sudden, Cardiac
Humans
Prognosis